Biogen Inc. buy BMO Capital Markets
Start price
14.02.24
/
50%
€206.60
Target price
14.02.25
€265.53
Performance (%)
-35.26%
End price
15.02.25
€133.75
Summary
This prediction ended on 15.02.25 with a price of €133.75. The BUY prediction by BMO_Capital_Markets for Biogen Inc. performed very badly with a performance of -35.26%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 0.525% | 0.525% | 57.143% |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $295.00 to $285.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten